Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q2 EPS of ($0.50), $0.20 better than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.